Jon G. Ayres

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, Richard Beasley, Jon G. Ayres et al. · Allergy · 2004 · 1.1K citations · Full text

Acute Effects of Particulate Air Pollution on Respiratory Admissions

Richard Atkinson, H R Anderson, Jordi Sunyer et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 659 citations

Evaluating the Toxicity of Airborne Particulate Matter and Nanoparticles by Measuring Oxidative Stress Potential—A Workshop Report and Consensus Statement

Jon G. Ayres, Paul J. A. Borm, Flemming R. Cassee et al. · Inhalation Toxicology · 2008 · 612 citations

Smoke-free Legislation and Hospitalizations for Childhood Asthma

Daniel Mackay, Sally Haw, Jon G. Ayres et al. · New England Journal of Medicine · 2010 · 306 citations

Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate‐to‐severe) allergic asthma

Jon G. Ayres, Bernard Higgins, Edwin R. Chilvers et al. · Allergy · 2004 · 276 citations